… BioPharma) and trastuzumab (Herceptin; Genentech) demonstrated clinically meaningful … (HER2)-mutated metastatic breast cancer (MBC). Mutations in … HER2-mutated metastatic breast cancer: a phase 2 … with advanced HER2+ breast cancer (HER2CLIMB). Updated August …

… IDFS) compared with trastuzumab (Herceptin; Genentech) alone in patients … 2–positive (HER2+) early breast cancer (EBC). The data, published … patients with HER2-positive breast cancer who have residual … in residual HER2-positive breast cancer. N J Engl Med …

… based chemotherapy.1 HER2+ breast cancer (BC) subtypes are aggressive … escalation immunotherapy regimen with trastuzumab (Herceptin; Genentech), pertuzumab (Perjeta; … modern immunotherapy to optimize breast cancer treatment—through improved effectiveness …

… , MD, MBA, CPHQ, clinical director, Breast Cancer Medical Oncology Program, University Hospitals … breast cancer who had received at least 3 prior regimens, including trastuzumab (Herceptin … or other HER2-overexpressing non-breast cancers. In part b of the …

… 47;HER2-negative positive breast cancer. The new targeted … such as Herceptin (trastuzumab). About 70% of breast cancer cases … positive, HER2-negative metastatic breast cancer treatment landscape, new … patients with metastatic breast cancer a new treatment …

… breast tumors. PFS and DOR outcomes in patients with breast cancer … non-breast cancers compared with the overall breast cancer cohort … HER2-positive breast cancer, HER2-low breast cancer, colorectal cancer … antibody trastuzumab (Herceptin), a cleavable linker …

… a predictive biomarker in metastatic breast cancer treated with conjugated and … -positive disease treated with trastuzumab (Herceptin), pertuzumab (Perjeta), and taxane … at the 2024 San Antonio Breast Cancer Symposium revealed significant associations …

… positive (HER2+) metastatic breast cancer (MBC), according … Comprehensive Cancer Network Breast Cancer Clinical Practice … Genentech) with trastuzumab (Herceptin; Roche), alongside taxane … patients with metastatic breast cancer. Updated September 21 …

… anti-HER2 therapy of trastuzumab (Herceptin; Genentech, Inc) or trastuzumab … 47;www.oncologynewscentral.com/breast-cancer/trastuzumab-deruxtecan-outperforms-chemo … inavolisib approvals highlight advances in breast cancer care. Pharmacy Times. December …

… treatments for early breast cancer were administered either … HER2-positive early breast cancer who receive neoadjuvant … HER2-positive metastatic breast cancer,” Geyer said. … HER2-positive breast cancer previously treated with trastuzumab [Herceptin, Genentech …